Abstract

) The Biostatistical Core supports the activities that are essential to the smooth functioning and interaction of the SPORE in Ovarian Cancer. This core functions to provide overall coordination of the three Research Programs and the Scientific Cores. In addition, this core is responsible for administration of the Career Development Program and the Developmental Research Program. The Internal and External Advisory Committees are coordinated through this core and, along with the Executive Committee of the SPORE are responsible for scientific planning and evaluation. The core is also responsible for the statistical planning, analysis and data management for each of the Research Programs and Developmental Projects. In addition, the core will also provide for maintenance and reconciliation of budgets and accounts, assist in acquisition of supplies and handle personnel management.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA083591-04
Application #
6660937
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2002-09-30
Project End
2003-09-29
Budget Start
Budget End
Support Year
4
Fiscal Year
2002
Total Cost
Indirect Cost

  Institution

Name
University of Alabama Birmingham
Department
Type
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294

  Publications

Skates, Steven J; Greene, Mark H; Buys, Saundra S et al. (2017) Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials. Clin Cancer Res 23:3628-3637
Ren, Yi A; Mullany, Lisa K; Liu, Zhilin et al. (2016) Mutant p53 Promotes Epithelial Ovarian Cancer by Regulating Tumor Differentiation, Metastasis, and Responsiveness to Steroid Hormones. Cancer Res 76:2206-18
Nelson, Carol A; Azure, Michael T; Adams, Christopher T et al. (2014) The somatostatin analog 188Re-P2045 inhibits the growth of AR42J pancreatic tumor xenografts. J Nucl Med 55:2020-5
Kim, Kenneth H; Dmitriev, Igor; O'Malley, Janis P et al. (2012) A phase I clinical trial of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in patients with recurrent gynecologic cancer. Clin Cancer Res 18:3440-51
Kimball, Kristopher J; Preuss, Meredith A; Barnes, Mack N et al. (2010) A phase I study of a tropism-modified conditionally replicative adenovirus for recurrent malignant gynecologic diseases. Clin Cancer Res 16:5277-87
Borovjagin, Anton V; McNally, Lacey R; Wang, Minghui et al. (2010) Noninvasive monitoring of mRFP1- and mCherry-labeled oncolytic adenoviruses in an orthotopic breast cancer model by spectral imaging. Mol Imaging 9:59-75
Szafran, April Adams; Folks, Karri; Warram, Jason et al. (2009) Death receptor 5 agonist TRA8 in combination with the bisphosphonate zoledronic acid attenuated the growth of breast cancer metastasis. Cancer Biol Ther 8:1109-16
Matsumura, Noriomi; Huang, Zhiqing; Baba, Tsukasa et al. (2009) Yin yang 1 modulates taxane response in epithelial ovarian cancer. Mol Cancer Res 7:210-20
Bell, Walter C; Sexton, Katherine C; Grizzle, William E (2009) How to efficiently obtain human tissues to support specific biomedical research projects. Cancer Epidemiol Biomarkers Prev 18:1676-9
Meredith, Ruby F; Shen, Sui; Forero, Andres et al. (2008) A method to correct for radioactivity in large vessels that overlap the spine in imaging-based marrow dosimetry of lumbar vertebrae. J Nucl Med 49:279-84

Showing the most recent 10 out of 114 publications